Paper2170702
Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.
Alter MJ and 9 others. JAMA, 1990. Cited by 581 papers, by iCite.
Cite this record
ConductScience Library. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. Papers, record 2170702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2170702
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepacivirus | Major topic |
| Hepatitis Antibodies | Major topic |
| Hepatitis C | Major topic |
| Acute Disease | |
| Adolescent | |
| Adult | |
| Female | |
| Humans | |
| Immunoglobulin M | |
| Incidence | |
| Male | |
| Middle Aged | |
| Population Surveillance | |
| Risk Factors | |
| Socioeconomic Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FDA 224-85-1001 | FDA HHS | United States | PubMed |
Source PubMed
Cited by102
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 581 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39820923 | Looking back into the Hepatitis C Virus epidemic dynamics from Unnao, India through phylogenetic approach. | PLoS One | 2025 | https://conductscience.org/library/papers/39820923 | PubMed |
| 38357186 | Prevalence and predictors of hepatitis C infection among antenatal attendees in a tertiary hospital in Southern Nigeria. | Afr Health Sci | 2023 | https://conductscience.org/library/papers/38357186 | PubMed |
| 34307975 | Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis Population. | Kidney Int Rep | 2021 | https://conductscience.org/library/papers/34307975 | PubMed |
| 33283768 | Outcome of hepatitis C patients in a community with predominant genotype 3 with standard-of-care treatment before and after advent of direct-acting antivirals: A retrospective-cum-prospective study. | Indian J Pharmacol | 2020 | https://conductscience.org/library/papers/33283768 | PubMed |
| 31669367 | Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore. | Infect Genet Evol | 2020 | https://conductscience.org/library/papers/31669367 | PubMed |
| 30496620 | The association of hepatitis C infection with the onset of CKD and progression into ESRD. | Semin Dial | 2019 | https://conductscience.org/library/papers/30496620 | PubMed |
| 28721349 | Hepatocellular carcinoma: early-stage management challenges. | J Hepatocell Carcinoma | 2017 | https://conductscience.org/library/papers/28721349 | PubMed |
| 26060718 | Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients. | Iran J Public Health | 2014 | https://conductscience.org/library/papers/26060718 | PubMed |
| 25602859 | A window of opportunity: maximizing the effectiveness of new HCV regimens in the United States with the expansion of the Affordable Care Act. | Am J Public Health | 2015 | https://conductscience.org/library/papers/25602859 | PubMed |
| 25385677 | Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis. | Eur J Epidemiol | 2015 | https://conductscience.org/library/papers/25385677 | PubMed |
| 24922169 | Mortality from sexually transmitted diseases in reproductive-aged women: United States, 1999-2010. | Am J Public Health | 2014 | https://conductscience.org/library/papers/24922169 | PubMed |
| 24678168 | Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays. | Asian J Transfus Sci | 2014 | https://conductscience.org/library/papers/24678168 | PubMed |
| 24654657 | Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis. | Aliment Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24654657 | PubMed |
| 24307785 | Scotomas in molecular virology and epidemiology of hepatitis C virus. | World J Gastroenterol | 2013 | https://conductscience.org/library/papers/24307785 | PubMed |
| 23382662 | Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. | PLoS Comput Biol | 2013 | https://conductscience.org/library/papers/23382662 | PubMed |
| 22514404 | Risk of hepatitis C virus infection from tattooing and other skin piercing services. | Can J Infect Dis | 1995 | https://conductscience.org/library/papers/22514404 | PubMed |
| 22346493 | Analysis of risk factors associated with hepatitis B and C infection in correctional institutions in British Columbia. | Can J Infect Dis | 1994 | https://conductscience.org/library/papers/22346493 | PubMed |
| 22346447 | Hepatitis C: Recent advances. | Can J Infect Dis | 1993 | https://conductscience.org/library/papers/22346447 | PubMed |
| 22131862 | Jewellery- and ornament-related injuries in children and adolescents. | Paediatr Child Health | 2010 | https://conductscience.org/library/papers/22131862 | PubMed |
| 22046225 | Prisons and public health. | Open Med | 2011 | https://conductscience.org/library/papers/22046225 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2170702
GET https://conductscience.org/api/papers/v1/2170702/cited_by?page=2